High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma

Miriam Lynn, Yuexiang Wang, Jaime Slater, Naisha Shah, Judith Conroy, Sean Ennis, Thomas Morris, David R. Betts, Jonathan A. Fletcher, Maureen J. O'Sullivan

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Ewing sarcoma family tumors are aggressive sarcomas of childhood and adolescence with continuing poor outcomes. Decades of research on the characteristics of the often solitaryknown oncogenic-genomic aberration in Ewing sarcoma family tumors, namely a TET-ETS fusion, have provided little advancement in the understanding of the molecular pathogenesis of Ewing sarcoma or treatment thereof. In this study, the highresolution single-nucleotide polymorphism technology was used to identify additional/secondary copy-number alterations (CNAs) in Ewing sarcoma that might elucidate the aggressive biology of this sarcoma. We compared paired constitutional and tumor DNA samples. Commonly known genomic alterations including gain of 1q and chromosome 8 were the most frequently detected changes in this study. In addition, deletions and loss of heterozygosity were identified in 10q, 11p, and 17p. Furthermore, tumor-specific CNAs were identified not only in genes previously known to be of interest, including CDKN2A, but also in genes not previously associated with Ewing sarcoma, including SOX6 and PTEN. Selected array-based findings were confirmed by fluorescence in situ hybridization, immunohistochemical studies, or sequencing. The results highlight an unexpected level of cytogenetic complexity associated with several of the samples, 2 of which contained TP53 mutations. In summary, our high-resolution genome-wide copy-number data identify several novel CNAs associated with Ewing sarcoma, which are promising targets for novel therapeutic strategies in this aggressive sarcoma.

LanguageEnglish
Pages76-84
Number of pages9
JournalDiagnostic Molecular Pathology
Volume22
Issue number2
DOIs
Publication statusPublished - 1 Jun 2013

Keywords

  • Copy-number alteration
  • Ewing sarcoma
  • Genome-wide copy-number analysis
  • Peripheral primitive neuroectodermal tumor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Lynn, Miriam ; Wang, Yuexiang ; Slater, Jaime ; Shah, Naisha ; Conroy, Judith ; Ennis, Sean ; Morris, Thomas ; Betts, David R. ; Fletcher, Jonathan A. ; O'Sullivan, Maureen J. / High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma. In: Diagnostic Molecular Pathology. 2013 ; Vol. 22, No. 2. pp. 76-84.
@article{7e4f255e3887446cb3af4e1f170831ad,
title = "High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma",
abstract = "Ewing sarcoma family tumors are aggressive sarcomas of childhood and adolescence with continuing poor outcomes. Decades of research on the characteristics of the often solitaryknown oncogenic-genomic aberration in Ewing sarcoma family tumors, namely a TET-ETS fusion, have provided little advancement in the understanding of the molecular pathogenesis of Ewing sarcoma or treatment thereof. In this study, the highresolution single-nucleotide polymorphism technology was used to identify additional/secondary copy-number alterations (CNAs) in Ewing sarcoma that might elucidate the aggressive biology of this sarcoma. We compared paired constitutional and tumor DNA samples. Commonly known genomic alterations including gain of 1q and chromosome 8 were the most frequently detected changes in this study. In addition, deletions and loss of heterozygosity were identified in 10q, 11p, and 17p. Furthermore, tumor-specific CNAs were identified not only in genes previously known to be of interest, including CDKN2A, but also in genes not previously associated with Ewing sarcoma, including SOX6 and PTEN. Selected array-based findings were confirmed by fluorescence in situ hybridization, immunohistochemical studies, or sequencing. The results highlight an unexpected level of cytogenetic complexity associated with several of the samples, 2 of which contained TP53 mutations. In summary, our high-resolution genome-wide copy-number data identify several novel CNAs associated with Ewing sarcoma, which are promising targets for novel therapeutic strategies in this aggressive sarcoma.",
keywords = "Copy-number alteration, Ewing sarcoma, Genome-wide copy-number analysis, Peripheral primitive neuroectodermal tumor",
author = "Miriam Lynn and Yuexiang Wang and Jaime Slater and Naisha Shah and Judith Conroy and Sean Ennis and Thomas Morris and Betts, {David R.} and Fletcher, {Jonathan A.} and O'Sullivan, {Maureen J.}",
year = "2013",
month = "6",
day = "1",
doi = "10.1097/PDM.0b013e31827a47f9",
language = "English",
volume = "22",
pages = "76--84",
journal = "Diagnostic Molecular Pathology",
issn = "1052-9551",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Lynn, M, Wang, Y, Slater, J, Shah, N, Conroy, J, Ennis, S, Morris, T, Betts, DR, Fletcher, JA & O'Sullivan, MJ 2013, 'High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma', Diagnostic Molecular Pathology, vol. 22, no. 2, pp. 76-84. https://doi.org/10.1097/PDM.0b013e31827a47f9

High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma. / Lynn, Miriam; Wang, Yuexiang; Slater, Jaime; Shah, Naisha; Conroy, Judith; Ennis, Sean; Morris, Thomas; Betts, David R.; Fletcher, Jonathan A.; O'Sullivan, Maureen J.

In: Diagnostic Molecular Pathology, Vol. 22, No. 2, 01.06.2013, p. 76-84.

Research output: Contribution to journalArticle

TY - JOUR

T1 - High-resolution genome-wide copy-number analyses identify localized copy-number alterations in Ewing sarcoma

AU - Lynn, Miriam

AU - Wang, Yuexiang

AU - Slater, Jaime

AU - Shah, Naisha

AU - Conroy, Judith

AU - Ennis, Sean

AU - Morris, Thomas

AU - Betts, David R.

AU - Fletcher, Jonathan A.

AU - O'Sullivan, Maureen J.

PY - 2013/6/1

Y1 - 2013/6/1

N2 - Ewing sarcoma family tumors are aggressive sarcomas of childhood and adolescence with continuing poor outcomes. Decades of research on the characteristics of the often solitaryknown oncogenic-genomic aberration in Ewing sarcoma family tumors, namely a TET-ETS fusion, have provided little advancement in the understanding of the molecular pathogenesis of Ewing sarcoma or treatment thereof. In this study, the highresolution single-nucleotide polymorphism technology was used to identify additional/secondary copy-number alterations (CNAs) in Ewing sarcoma that might elucidate the aggressive biology of this sarcoma. We compared paired constitutional and tumor DNA samples. Commonly known genomic alterations including gain of 1q and chromosome 8 were the most frequently detected changes in this study. In addition, deletions and loss of heterozygosity were identified in 10q, 11p, and 17p. Furthermore, tumor-specific CNAs were identified not only in genes previously known to be of interest, including CDKN2A, but also in genes not previously associated with Ewing sarcoma, including SOX6 and PTEN. Selected array-based findings were confirmed by fluorescence in situ hybridization, immunohistochemical studies, or sequencing. The results highlight an unexpected level of cytogenetic complexity associated with several of the samples, 2 of which contained TP53 mutations. In summary, our high-resolution genome-wide copy-number data identify several novel CNAs associated with Ewing sarcoma, which are promising targets for novel therapeutic strategies in this aggressive sarcoma.

AB - Ewing sarcoma family tumors are aggressive sarcomas of childhood and adolescence with continuing poor outcomes. Decades of research on the characteristics of the often solitaryknown oncogenic-genomic aberration in Ewing sarcoma family tumors, namely a TET-ETS fusion, have provided little advancement in the understanding of the molecular pathogenesis of Ewing sarcoma or treatment thereof. In this study, the highresolution single-nucleotide polymorphism technology was used to identify additional/secondary copy-number alterations (CNAs) in Ewing sarcoma that might elucidate the aggressive biology of this sarcoma. We compared paired constitutional and tumor DNA samples. Commonly known genomic alterations including gain of 1q and chromosome 8 were the most frequently detected changes in this study. In addition, deletions and loss of heterozygosity were identified in 10q, 11p, and 17p. Furthermore, tumor-specific CNAs were identified not only in genes previously known to be of interest, including CDKN2A, but also in genes not previously associated with Ewing sarcoma, including SOX6 and PTEN. Selected array-based findings were confirmed by fluorescence in situ hybridization, immunohistochemical studies, or sequencing. The results highlight an unexpected level of cytogenetic complexity associated with several of the samples, 2 of which contained TP53 mutations. In summary, our high-resolution genome-wide copy-number data identify several novel CNAs associated with Ewing sarcoma, which are promising targets for novel therapeutic strategies in this aggressive sarcoma.

KW - Copy-number alteration

KW - Ewing sarcoma

KW - Genome-wide copy-number analysis

KW - Peripheral primitive neuroectodermal tumor

UR - http://www.scopus.com/inward/record.url?scp=84879936495&partnerID=8YFLogxK

U2 - 10.1097/PDM.0b013e31827a47f9

DO - 10.1097/PDM.0b013e31827a47f9

M3 - Article

VL - 22

SP - 76

EP - 84

JO - Diagnostic Molecular Pathology

T2 - Diagnostic Molecular Pathology

JF - Diagnostic Molecular Pathology

SN - 1052-9551

IS - 2

ER -